US Archives - Page 5 of 215 - European Medical Journal

Cognition and Treatment Choice in Prostate Cancer

Data from the innovative, patient-centered, Phase II ARACOG study presented at ASCO 2026, evaluating cognitive outcomes with darolutamide…

Immunotherapy Safety in Hepatitis C

This work addresses an important evidence gap in the use of immune checkpoint inhibitors among patients with pre-existing hepatitis C virus…

Redefining First-Line Therapy In HER2+ mBC

Data presented at ASCO 2026, ESMO 2025/26, and SABCS 2025 from DESTINY-Breast03 and DESTINY-Breast09 evaluated T-DXd…

Reducing Brain Metastases in Breast Cancer

Brain metastases (BM) represent one of the most clinically significant complications of human epidermal growth factor receptor 2…

ctDNA-Guided Therapy in Colorectal Cancer

Previous studies have demonstrated that patients with RAS-mutant metastatic colorectal cancer (mCRC) occasionally develop RAS wild-type…

Targeting DLL3 in Small Cell Lung Cancer

Updated data from the Phase I DAREON-8 trial of the novel DLL3 targeting T-cell engager, obrixtamig, presented at ASCO 2026, showing…

ASCO 2026: New Directions in HR+ Breast Cancer

ASCO 2026 highlights in HR+ metastatic breast cancer include new insights into endocrine resistance, ctDNA-guided monitoring…

AI Predicts Colorectal Cancer Signatures

Molecular profiling has advanced colorectal cancer (CRC) research but remains limited in the clinic due to cost and tissue constraints…

Building a More Accessible Future for Cancer Care: Interview with Christopher Cogle

Moving back and forth among the bedside, the laboratory, and the policy arena has given me a wide view of health. As a medical oncologist…

Doctor completing a medical screening questionnaire for leprosy detection.

Prison Screening Exposes Hidden Burden of Leprosy

Leprosy screening identified undiagnosed multibacillary disease and disability among incarcerated men in northeastern Brazil.